Home » Newsletters » BioWorld Science

BioWorld Science

July 25, 2012

View Archived Issues

Researchers at Leo Pharma patent novel ingenol compounds

Candidate Syntaxin drug for acromegaly has new mode of action

New NK3 receptor antagonists presented by Roche

New antifungals prepared at Janssen Pharmaceutica

Eutropics Pharmaceuticals discloses novel Mcl-1/Bcl-XL inhibitors

New IGF-I receptor inhibitors reported by Boehringer Ingelheim

Janssen Pharmaceutica divulges new BACE1 inhibitors

Belgian-Dutch collaboration yields candidate biomarker for use in kidney transplant recipients

Novel OGA inhibitors designed

BioCryst reports on two phase II trials of BCX-4208

Data presented on sustained-release plug for glaucoma

Recruitment begins in phase II NKTR-181 trial

First preclinical candidate drug selected in osteoarthritis alliance

Merck & Co. provides update on anti-HIV drug development

Dynavax submits MAA for Heplisav hepatitis B vaccine

Sarepta drug shows clinical benefit in Duchenne muscular dystrophy

Ongoing conference features new data on anti-HIV/HSV combination gel

Pfizer reports topline results from first of four phase III bapineuzumab studies

First patient treated in study of subcutaneous Debio-8206

Biofrontera holds meeting with FDA regarding planned application for Ameluz

FDA grants priority review to enzalutamide NDA

FDA issues safety communication regarding Ampyra

Anticancer drug shows promise to treat Alzheimer's disease

Psyadon halts ecopipam study based on promising interim results

SRI receives NIAID grant for development of bioadhesive gel

European Commission approves combination tablet for type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...